Erlanger nurse stole fentanyl and AI missed it, state records say

A nurse at Erlanger Hospital in Chattanooga, Tennessee’s largest medical facility, diverted and abused fentanyl left over from surgeries for months before being caught. Staff noticed the nurse’s impaired behavior while on duty, leading to a drug test that confirmed substance abuse. The nurse later admitted to stealing fentanyl daily, a case that stands out due to the hospital’s use of Sentri7, AI-powered medication-monitoring software designed to detect drug diversions. The software, provided by Wolters Kluwer, failed to flag missing drugs or inconsistencies for months, despite fentanyl theft being a common and well-documented method of diversion. The Tennessee Board of Nursing’s consent order describes this as an apparent failure of AI surveillance, which is used in hundreds of U.S. hospitals without mandatory transparency or oversight. Hospitals are not required to disclose AI software use or report malfunctions, leaving gaps in accountability. Experts warn that proprietary AI systems and limited hospital understanding of their functionality allow errors to go unaddressed. David Rastall, a neurologist and AI researcher at Johns Hopkins Medicine, emphasized the need for public disclosure when AI failures occur to prevent repeated mistakes. The Drug Enforcement Administration mandates confidential reporting of lost or stolen drugs, but these reports do not include details about AI software involvement. Jacob Smith, a pharmacist overseeing drug security at Johns Hopkins, questioned how the AI missed such a basic diversion case. Terri Vidals, founder of Rxpert Solutions, suggested the failure might stem from user error rather than software malfunction. Wolters Kluwer declined to comment on the Erlanger incident but stated confidence in Sentri7’s capabilities. The case raises concerns about the reliability of AI in healthcare and the lack of industry standards for monitoring and reporting failures. With no public record of similar AI shortcomings, the Erlanger incident remains an isolated but critical example of potential systemic risks in hospital drug security.